Literature DB >> 27048896

Probiotics and prebiotics in infectious gastroenteritis.

Yvan Vandenplas1.   

Abstract

Acute gastroenteritis (AGE) is worldwide a common problem in infants and children. While AGE is still an important cause of morbidity and mortality in developing countries, it is mainly a problem with high socioeconomic impact in the rest of the world. Oral rehydration solutions (ORS) and rapid refeeding remain the cornerstone of the management. However, ORS does not decrease the duration of diarrhea. There is evidence that selected strains of probiotics decrease the duration of AGE with 24 h, both in ambulatory care and in hospitalized children, resulting also in a decrease of the duration of hospitalization. Synbiotics are equally effective as probiotics alone, but prebiotics are not effective. Both pro- and prebiotics have limited to no efficacy in the prevention of AGE. The administration of pre- and probiotics is considered to be safe, even in newborns. Only these pre-, pro and synbiotics that have been clinically tested can be recommended.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute gastroenteritis; Diarrhea; Gastro-intestinal microbiota; Microbiome; Prebiotic; Probiotic; Synbiotic

Mesh:

Substances:

Year:  2015        PMID: 27048896     DOI: 10.1016/j.bpg.2015.12.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  8 in total

Review 1.  Role of Microbiota in Viral Infections and Pathological Progression.

Authors:  Taketoshi Mizutani; Aya Ishizaka; Michiko Koga; Takeya Tsutsumi; Hiroshi Yotsuyanagi
Journal:  Viruses       Date:  2022-05-01       Impact factor: 5.818

Review 2.  Viral Infections, the Microbiome, and Probiotics.

Authors:  Ashton Harper; Vineetha Vijayakumar; Arthur C Ouwehand; Jessica Ter Haar; David Obis; Jordi Espadaler; Sylvie Binda; Shrilakshmi Desiraju; Richard Day
Journal:  Front Cell Infect Microbiol       Date:  2021-02-12       Impact factor: 6.073

3.  Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors.

Authors:  Tomohiro Kawahara; Yutaka Makizaki; Yosuke Oikawa; Yoshiki Tanaka; Ayako Maeda; Masaki Shimakawa; Satoshi Komoto; Kyoko Moriguchi; Hiroshi Ohno; Koki Taniguchi
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

4.  Effect of Simulated Gastrointestinal Tract Conditions on Survivability of Probiotic Bacteria Present in Commercial Preparations.

Authors:  Lidia Stasiak-Różańska; Anna Berthold-Pluta; Antoni Stanisław Pluta; Krzysztof Dasiewicz; Monika Garbowska
Journal:  Int J Environ Res Public Health       Date:  2021-01-27       Impact factor: 3.390

Review 5.  Clinical Trials of Probiotics in Patients With Irritable Bowel Syndrome: Some Points to Consider.

Authors:  Eamonn M M Quigley
Journal:  J Neurogastroenterol Motil       Date:  2022-04-30       Impact factor: 4.924

6.  Colloidal Silicon Dioxide in Tablet form (Carbowhite) Efficacy in Patients with Acute Diarrhea: Results of Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study.

Authors:  Vadim Tieroshyn; Larisa Moroz; Oleksandra Prishliak; Lyudmila Shostakovich-Koretska; Oksana Kruglova; Lyudmila Gordienko
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

7.  The Effect of Encapsulated Powder of Goji Berry (Lycium barbarum) on Growth and Survival of Probiotic Bacteria.

Authors:  Prodromos Skenderidis; Chrysanthi Mitsagga; Dimitrios Lampakis; Konstantinos Petrotos; Ioannis Giavasis
Journal:  Microorganisms       Date:  2019-12-28

8.  Correlation of Knowledge, Attitude, and Practice Toward Probiotics for the Digestive System Among Health Science Students.

Authors:  Pinka Alia Rahmah; Astrid Feinisa Khairani; Nur Atik; Nita Arisanti; Siti Nur Fatimah
Journal:  J Multidiscip Healthc       Date:  2021-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.